Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/24/2009US20090318556 Biomarkers for detecting radiation exposure: methods and uses thereof
12/24/2009US20090318555 Treatment of Vertigo with Acetyl-L-Leucine
12/24/2009US20090318553 Use Of Docosahexaenoic Glycerides For The Treatment Of Tumorous Diseases
12/24/2009US20090318552 Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizo dor treating or preventing diabetes mellitus and the use thereof
12/24/2009US20090318551 Uses of analogs of 3-o-acetyl-11-keto-beta-boswellic acid
12/24/2009US20090318550 Emulsions comprising at least one retinoid and benzoyl peroxide
12/24/2009US20090318549 Combination treatment of glaucoma
12/24/2009US20090318548 Para-quinol derivatives and methods of stereo selectively synthesizing and using same
12/24/2009US20090318547 Glucopyranosyl-substituted difluorobenzyl-benzene derivates, medicaments containing such compounds, their use and process for their manufacture
12/24/2009US20090318546 Chromen-2-One Derivatives
12/24/2009US20090318545 Mast cell inhibition in diseases of the retina and vitreous
12/24/2009US20090318544 Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
12/24/2009US20090318543 C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes
12/24/2009US20090318542 Ophthamological drugs
12/24/2009US20090318541 such as tert-butyl [(1S)-1-benzyl-2-({2-[(hydroxyamino)carbonyl]-1-benzothien-6-yl}amino)ethyl]carbamate, exhibiting histone deacetylase inhibitory activity, used for treating cancer, autoimmune, allergic, inflammatory and neurodegenerative diseases
12/24/2009US20090318539 Process for Preparing a Particle Comprising a Biological Molecule and a Carrier Polymer
12/24/2009US20090318538 Polymeric oligonucleotide prodrugs
12/24/2009US20090318537 Silencing of tgf beta type ii receptor expression by sirna
12/24/2009US20090318536 Methods for treating hypercholesterolemia
12/24/2009US20090318533 Annexin A9 (ANXA9) Biomarker and Therapeutic Target in Epithelial Cancer
12/24/2009US20090318532 Compounds and methods for modulating expression of ptp1b
12/24/2009US20090318530 Pharmaceutical compositions comprising nk1 receptor antagonists and sodium channel blockers
12/24/2009US20090318529 Fermentation product of marine actinomyces strains; antiproliferative agents; anticarcinogenic agents; low molecular weight, high pharmaceutical potency, and selectivity for cancer cells
12/24/2009US20090318528 Hydrate crystals
12/24/2009US20090318527 Indole compounds and methods of use thereof
12/24/2009US20090318526 Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
12/24/2009US20090318525 Process For Preparing A 3-Pyrrole Substituted 2-Indolinone Malate Salt
12/24/2009US20090318524 Bicyclic tetrahydropyrrole compounds
12/24/2009US20090318523 Benzoisoindole derivatives and their use as ep4 receptor agonists
12/24/2009US20090318522 comprising oxybutynin and pilocarpine; drug releasing pilocarpine between about 30 minutes to about 60 minutes after oxybutynin is released; treating overactive bladder; urogenital disorders
12/24/2009US20090318521 Synthesis of 4-Bromomethyl-2'-Formylbiphenyl and 4-Bromomethyl-2'-Hydroxymethylbiphenyl and Its Use in Preparation of Giotensin II Antagonists
12/24/2009US20090318520 Use of isoindoles for the treatment of neurobehavioral disorders
12/24/2009US20090318519 Process for release of biologically active species
12/24/2009US20090318518 Indole and indoline cyclopropyl amide derivatives as ep4 receptor antagonists
12/24/2009US20090318517 Novel Compounds 148
12/24/2009US20090318516 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
12/24/2009US20090318515 Succinimide derivatives as ocular hypotensive agents
12/24/2009US20090318514 Novel Pharmaceutical Compositions
12/24/2009US20090318513 Compounds exhibiting thrombopoietin receptor agonism
12/24/2009US20090318512 Methods of maintaining ocular tissue cell membrane integrity using cetylpyridinium chloride
12/24/2009US20090318511 Selective hydroxamate based mmp inhibitors
12/24/2009US20090318510 Topical drug delivery system
12/24/2009US20090318509 Oxime Derivatives as Inhibitors of Macrophage Migration Inhibitory Factor
12/24/2009US20090318508 Method for Treating Hair Growth Disorders, Such as Female Pattern Alopecia, and Compositions Useful Therefore
12/24/2009US20090318507 Potassium Channel Activators for the Prevention and Treatment of Dystonia and Dystonia Like Symptoms
12/24/2009US20090318506 Sulfonate salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
12/24/2009US20090318505 Fungicidal compositions
12/24/2009US20090318504 Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
12/24/2009US20090318503 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
12/24/2009US20090318502 Pharmaceutical Compositions Comprising a Hypoglycemic Agent and Methods of Using Same
12/24/2009US20090318501 Piperidine derivatives as renin inhibitors
12/24/2009US20090318500 4-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of Cancer
12/24/2009US20090318499 Compounds having analgesic and/or immunostimulant activity
12/24/2009US20090318498 Piperidyl acrylamide antagonists of ccr2
12/24/2009US20090318497 Substituted pyridylmethyl bicycliccarboxyamide compounds
12/24/2009US20090318496 Preparation containing fibrate agent and process for producing the same
12/24/2009US20090318494 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
12/24/2009US20090318493 Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
12/24/2009US20090318492 Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors
12/24/2009US20090318491 Cytisine and Acetylcholine Analogs and Methods of Treating Mood Disorders
12/24/2009US20090318490 Compounds and methods for promoting smoking cessation
12/24/2009US20090318489 Aporphine compounds and pharmaceutical use thereof
12/24/2009US20090318488 Pharmaceutically acceprable salts of aporphine compounds of carboxyl group-containing agents and methods for preparing the same
12/24/2009US20090318487 Methods for detection of promoter polymorphism in a UGT gene promoter
12/24/2009US20090318486 Tricyclic spiro derivatives as CRTH2 modulators
12/24/2009US20090318485 Novel inhibitors of rho kinase
12/24/2009US20090318484 Inhibitors of JNK
12/24/2009US20090318483 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
12/24/2009US20090318482 Tablet preparation without causing a tableting trouble
12/24/2009US20090318481 Potentiators Of Glutamate Receptors
12/24/2009US20090318480 Method for treating cancer harboring egfr mutations
12/24/2009US20090318479 Substituted ring fused azines and their use in cancer therapy
12/24/2009US20090318478 Quinazoline derivatives
12/24/2009US20090318477 Chemical compounds
12/24/2009US20090318476 Azacycloalkane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
12/24/2009US20090318475 Novel, Acyclically Substituted Furopyrimidine Derivatives and Use Thereof
12/24/2009US20090318474 Pyridine and pyrimidine derivatives as mglur 2 antagonists
12/24/2009US20090318473 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
12/24/2009US20090318472 Aminopyrazine derivatives and compositions
12/24/2009US20090318471 New Salts and Crystalline Salt Forms of an Indolinone Derivative
12/24/2009US20090318470 1-substituted-3-(naphthalen-1-ylsulfonyl)-5-(piperazin-1-yl)-1h-indazole compounds as 5-hydroxytryptamine-6 ligands
12/24/2009US20090318469 Use of Flibanserin for the Treatment of Sexual Disorders in Females
12/24/2009US20090318468 Pyrazole compounds 436
12/24/2009US20090318467 Novel heteroaryl carboxamide derivatives
12/24/2009US20090318465 Method for identifying compounds that act as insulin-sensitizers
12/24/2009US20090318464 New Pyridine Analogues V
12/24/2009US20090318463 Indolylmaleimide Derivatives
12/24/2009US20090318462 Protein kinase c zeta inhibition to treat vascular permeability
12/24/2009US20090318461 Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl) benzenesulfonic acid
12/24/2009US20090318460 Amorphous varenicline tartrate and process for the preparation thereof
12/24/2009US20090318459 Therapeutic Compositions Comprising a Specific Endothelin Receptor Antagonist and a PDE5 Inhibitor
12/24/2009US20090318458 Novel compounds and use thereof
12/24/2009US20090318457 Methods of Using hydrates and polymorphs of 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide
12/24/2009US20090318456 Substituted pteridines for the treatment and prevention of viral infections
12/24/2009US20090318455 Compounds and methods for treating inflammatory and fibrotic disorders
12/24/2009US20090318454 Novel antioxidants and methods of treatment
12/24/2009US20090318453 Postoperative adjuvant chemotherapy for gastric cancer
12/24/2009US20090318452 INHIBITORS OF p38
12/24/2009US20090318451 Morpholine dopamine agonists for the treatment of pain
12/24/2009US20090318450 Compositions for modulating a kinase cascade and methods of use thereof